Aurobindo Pharma acquires European pharma firm

10 Jul 2026via NSE FilingSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Aurobindo Pharma acquires European pharma firm. The acquisition is valued at ₹6,200 crore, boosting its European footprint. This strategic move enhances Aurobindo’s generics portfolio and manufacturing capabilities. The deal is expected to close by Q4FY25.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition

#Acquisition#Pharma#Expansion

Stocks mentioned

AUROPHARMAAUROPHARMA

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →